INmune Bio, Inc Earning Date (INMB)

USA |NASDAQ |USD

INMB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 2, 2022 Jun 2022 - - $-0.44
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 2, 2022 Jun 2022 - - $4.00

Inmune Bio, Inc's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.

INMB Earnings Date & History Chart

INMB Earnings & Revenue Forecast

INMB Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-2.77 $-3.11 $-2.43

INMB Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $-2.36 $-2.36 $-2.17

INMB Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

INMB Earnings Date & Revenue History

INMB Earnings History

|
Show More
Show More

INMB Revenue History

|
Show More
Show More

Inmune Bio, Inc Next Earnings Date & Report

INMB Next Earnings Date & Report Preview: Jun 2022 (FQ)

INMB's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.

Inmune Bio, Inc Previous Earnings Dates & Reports

INMB Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Inmune Bio, Inc's previous earnings date was May 3, 2022 for its fiscal quarter ended Mar 31, 2022.

INMB Previous Earnings Date & Report Recap: Dec 2021 (FY)

Inmune Bio, Inc's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

INMB's earnings per share (EPS) was $-1.86, beating the consensus analysts forecast of $-1.93 by -3.63% , and lower than the previous year's EPS (Dec 2020) by 84.16%.

Revenues were $-181.00K.

The company reported a net income of $-30.34M.

Inmune Bio, Inc reported a free cash flow of $-28.50M for its fiscal year, compared to $-8.94M a year ago.

The company ended the fiscal year with $16.08M in total debt, an increase of 9941.27% compared to the previous year.